Ieva Strele

Dr. Ieva Strele

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2014 in Diabetic Medicine
Verified
Journal Article
Closed access
PDF file
JMJ. A. McKnight
J. A. McKnight
SWS. H. Wild
S. H. Wild
MLM. J. E. Lamb
M. J. E. Lamb
MCM. N. Cooper
M. N. Cooper
TJT. W. Jones
T. W. Jones
KMK. M. Miller
K. M. Miller

28 April 2016 in Experimental and Clinical Endocrinology & Diabetes
Verified
Journal Article
Closed access
PDF file
Maija DambrovaMaija Dambrova
Maija Dambrova
GLG. Latkovskis
G. Latkovskis
JKJ. Kuka
J. Kuka
ISIeva Strele
Ieva Strele
IKI. Konrade
I. Konrade
ELE. Liepinsh
E. Liepinsh
Recent studies have revealed strong associations between systemic trimethylamine N-oxide (TMAO) levels, atherosclerosis and cardiovascular risk. In addition, plasma L-carnitine levels in patients with high TMAO concentrations predicted an increased risk for cardiovascular disease and incident major adverse cardiac events. The aim of the present study was to investigate the relation between TMAO and L-carnitine plasma levels and diabetes. Blood plasma samples were collected from 12 and 20 weeks old db/db mice and patients undergoing percutaneous coronary intervention. Diabetic compared to non-diabetic db/L mice presented 10-fold higher TMAO, but lower L-carnitine plasma concentrations at 12 weeks of age. After 8 weeks of observation, diabetic db/db mice had significantly increased body weight, insulin resistance and TMAO concentration in comparison to non-diabetic control. In 191 patients undergoing percutaneous coronary intervention the median (interquartile range) plasma concentration of TMAO was 1.8 (1.2–2.6) µmol/L. Analysis of the samples showed a bivariate association of TMAO level with age, total cholesterol and L-carnitine. The multivariate linear regression analysis revealed that, in addition to L-carnitine as the strongest predictor of log transformed TMAO (p<0.001), the parameters of age, diabetes status and body mass index (BMI) were independently associated with increased log transformed TMAO levels (p<0.01). Our data provide evidence that age, diabetes and BMI are associated with higher TMAO levels independently of L-carnitine. These data support the hypothesis of TMAO as a cardiovascular risk marker and warrant further investigation of TMAO for diabetes research applications.

1 October 2015 in Melanoma Research
Verified
Journal Article
Open access
SDSimona Doniņa
Simona Doniņa
ISIeva Strele
Ieva Strele
GPGuna Proboka
Guna Proboka
JAJurgis Auziņš
Jurgis Auziņš
PAPēteris Alberts
Pēteris Alberts
AMAina Muceniece
Aina Muceniece
An oncolytic, nonpathogenic ECHO-7 virus adapted for melanoma that has not been genetically modified (Rigvir) is approved and registered for virotherapy, an active and specific immunotherapy, in Latvia since 2004. The present retrospective study was carried out to determine the effectiveness of Rigvir in substage IB, IIA, IIB and IIC melanoma patients on time to progression and overall survival. White patients (N=79) who had undergone surgical excision of the primary melanoma tumour were included in this study. All patients were free from disease after surgery and classified into substages IB, IIA, IIB and IIC. Circulating levels of clinical chemistry parameters were recorded. Survival was analysed by Cox regression. Rigvir significantly (P<0.05) prolonged survival in substage IB–IIC melanoma patients following surgery compared with patients who were under observation (according to current guidelines). The hazard ratio for patients under observation versus treated with Rigvir was statistically significantly different: hazard ratio 6.27 for all, 4.39 for substage IIA–IIB–IIC and 6.57 for substage IIB–IIC patients. The follow-up period was not statistically different between both treatment groups. These results indicate that the patients treated with Rigvir had a 4.39–6.57-fold lower mortality than those under observation. In this study, there was no untoward side effect or discontinuation of Rigvir treatment. Safety assessment of adverse events graded according to NCI CTCAE did not show any value above grade 2 in Rigvir-treated patients. In conclusion, Rigvir significantly prolongs survival in early-stage melanoma patients without any side effect.

28 May 2020 in Thyroid®
Verified
Journal Article
Closed access
TITill Ittermann
Till Ittermann
DADiana Albrecht
Diana Albrecht
PAPetra Arohonka
Petra Arohonka
RBR. Bílek
R. Bílek
JCJoao J. de Castro
Joao J. de Castro
HVHenry Völzke
Henry Völzke
Background: Knowledge about the population's iodine status is important, because it allows adjustment of iodine supply and prevention of iodine deficiency. The validity and comparability of iodine-related population studies can be improved by standardization, which was one of the goals of the EUthyroid project. The aim of this study was to establish the first standardized map of iodine status in Europe by using standardized urinary iodine concentration (UIC) data. Materials and Methods: We established a gold-standard laboratory in Helsinki measuring UIC by inductively coupled plasma mass spectrometry. A total of 40 studies from 23 European countries provided 75 urine samples covering the whole range of concentrations. Conversion formulas for UIC derived from the gold-standard values were established by linear regression models and were used to postharmonize the studies by standardizing the UIC data of the individual studies. Results: In comparison with the EUthyroid gold-standard, mean UIC measurements were higher in 11 laboratories and lower in 10 laboratories. The mean differences ranged from −36.6% to 49.5%. Of the 40 postharmonized studies providing data for the standardization, 16 were conducted in schoolchildren, 13 in adults, and 11 in pregnant women. Median standardized UIC was <100 μg/L in 1 out of 16 (6.3%) studies in schoolchildren, while in adults 7 out of 13 (53.8%) studies had a median standardized UIC <100 μg/L. Seven out of 11 (63.6%) studies in pregnant women revealed a median UIC <150 μg/L. Conclusions: We demonstrate that iodine deficiency is still present in Europe, using standardized data from a large number of studies. Adults and pregnant women, particularly, are at risk for iodine deficiency, which calls for action. For instance, a more uniform European legislation on iodine fortification is warranted to ensure that noniodized salt is replaced by iodized salt more often. In addition, further efforts should be put on harmonizing iodine-related studies and iodine measurements to improve the validity and comparability of results.

1 May 2013 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
ESElina Skapare
Elina Skapare
IKIlze Konrade
Ilze Konrade
ELEdgars Liepinsh
Edgars Liepinsh
ISIeva Strele
Ieva Strele
MMMarina Makrecka-Kuka
Marina Makrecka-Kuka
Maija DambrovaMaija Dambrova
Maija Dambrova

14 April 2015 in Biomedical Chromatography
Verified
Journal Article
Closed access
PDF file
SGSolveiga Grinberga
Solveiga Grinberga
MDMaija Dambrova
Maija Dambrova
GLGustavs Latkovskis
Gustavs Latkovskis
ISIeva Strele
Ieva Strele
IKIlze Konrade
Ilze Konrade
OPOsvalds Pugovics
Osvalds Pugovics